183 related articles for article (PubMed ID: 399586)
1. A modified PAP (peroxidase-anti-peroxidase) staining technique using sera from patients with dengue hemorrhagic fever (DHF): 4 step PAP staining technique.
Okuno Y; Fukunaga T; Srisupaluck S; Fukai K
Biken J; 1979 Dec; 22(4):131-5. PubMed ID: 399586
[TBL] [Abstract][Full Text] [Related]
2. Serological and virological studies on patients with dengue hemorrhagic fever (DHF) in Chanthaburi province, Thailand. I. Serological studies on paired sera from DHF patients by neutralization (N), hemagglutination inhibition (HI) and staining tests.
Okuno Y; Fukunaga T; Srisupaluck S; Kasemsarn P; Dharakul C; Sangkawibha N
Biken J; 1980 Sep; 23(3):113-21. PubMed ID: 7458894
[TBL] [Abstract][Full Text] [Related]
3. Neutralization tests for dengue and Japanese encephalitis viruses by the focus reduction method using peroxidase-anti-peroxidase staining.
Okuno Y; Igarashi A; Fukai K
Biken J; 1978 Dec; 21(4):137-47. PubMed ID: 383069
[TBL] [Abstract][Full Text] [Related]
4. An application of PAP (peroxidase-anti-peroxidase) staining technique for the rapid titration of dengue virus type 4 infectivity.
Okuno Y; Sasao F; Fukunaga T; Fukai K
Biken J; 1977 Mar; 20(1):29-33. PubMed ID: 328006
[No Abstract] [Full Text] [Related]
5. Application of peroxidase-antiperoxidase (PAP) staining for detection and localization of dengue-2 antigen. I. In an endogenous peroxidase containing cell systems.
Churdboonchart V; Kamsattaya K; Yoksan S; Sinarachatanant P; Bhamarapravati N
Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):547-53. PubMed ID: 6152570
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production.
Yang KD; Yeh WT; Yang MY; Chen RF; Shaio MF
J Med Virol; 2001 Feb; 63(2):150-7. PubMed ID: 11170052
[TBL] [Abstract][Full Text] [Related]
7. Application of peroxidase-antiperoxidase (PAP) staining for detection and localization of dengue-2 viral antigen. II. Observations for the antibody enhancement activity in human monocytes.
Kamasanttaya K; Churdboonchart V; Yoksan S; Bhamarapravati N
Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):137-41. PubMed ID: 3313732
[TBL] [Abstract][Full Text] [Related]
8. Precipitating antibodies to non-treated dengue type 2 viral antigens in sera of Thai hemorrhagic fever patients by crossed immunoelectrophoresis.
Wongtunyakorn N; Churdboonchart V; Bhamarapravati N; Futrakul P
Southeast Asian J Trop Med Public Health; 1985 Mar; 16(1):73-7. PubMed ID: 4023818
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses to an immunodominant nonstructural 1 synthetic peptide in patients with dengue fever and dengue hemorrhagic fever.
Huang JH; Wey JJ; Sun YC; Chin C; Chien LJ; Wu YC
J Med Virol; 1999 Jan; 57(1):1-8. PubMed ID: 9890415
[TBL] [Abstract][Full Text] [Related]
10. Complement fixation blocking activity of anti-dengue IgM antibody.
Scott RM; Russell PK
J Immunol; 1972 Oct; 109(4):875-7. PubMed ID: 5074335
[No Abstract] [Full Text] [Related]
11. Antibodies from patients with dengue viral infection mediate cellular cytotoxicity.
García G; Arango M; Pérez AB; Fonte L; Sierra B; Rodríguez-Roche R; Aguirre E; Fiterre I; Guzmán MG
J Clin Virol; 2006 Sep; 37(1):53-7. PubMed ID: 16787760
[TBL] [Abstract][Full Text] [Related]
12. Serological studies on a case of laboratory dengue infection.
Okuno Y; Fukunaga T; Tadano M; Fukai K
Biken J; 1982 Dec; 25(4):163-70. PubMed ID: 6307255
[TBL] [Abstract][Full Text] [Related]
13. [The standardization of the plaque reduction technic for differentiating a dengue infection from a yellow fever infection].
Alvarez Vera M; Valdés Palacios D; Vázquez Ramudo S; Delgado Hernández I; García Infante S; Morier Díaz L; Guzmán Tirado MG
Rev Cubana Med Trop; 1998; 50(3):177-81. PubMed ID: 10349439
[TBL] [Abstract][Full Text] [Related]
14. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.
Yeh WT; Chen RF; Wang L; Liu JW; Shaio MF; Yang KD
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):84-90. PubMed ID: 16965355
[TBL] [Abstract][Full Text] [Related]
15. [Use of an inhibition method of ELISA in the serologic diagnosis of dengue. Preliminary report].
Vázquez Ramudo S; Fernández Llanes R
Rev Cubana Med Trop; 1989; 41(1):18-26. PubMed ID: 2672168
[TBL] [Abstract][Full Text] [Related]
16. Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses.
Halstead SB; Udomsakdi S; Simasthien P; Singharaj P; Sukhavachana P; Nisalak A
Yale J Biol Med; 1970 Apr; 42(5):261-75. PubMed ID: 4986747
[No Abstract] [Full Text] [Related]
17. Rapid titration of dengue virus type 4 infectivity by counting fluorescent foci.
Igarashi A; Mantani M
Biken J; 1974 Sep; 17(3):87-93. PubMed ID: 4218091
[No Abstract] [Full Text] [Related]
18. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
Kuruvilla JG; Troyer RM; Devi S; Akkina R
Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
[TBL] [Abstract][Full Text] [Related]
19. Dengue virus cross-reactive hemagglutination inhibition antibody responses in patients with primary dengue virus infection.
Anantapreecha S; A-Nuegoonpipat A; Prakrong S; Chanama S; Sa-Ngasang A; Sawanpanyalert P; Kurane I
Jpn J Infect Dis; 2007 Sep; 60(5):267-70. PubMed ID: 17881865
[TBL] [Abstract][Full Text] [Related]
20. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.
Lin CF; Lei HY; Shiau AL; Liu CC; Liu HS; Yeh TM; Chen SH; Lin YS
J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
